3-(THIAZOLIDIN-3-YL)RHODANINES - A NOVEL CLASS OF RHODANINE DERIVATIVES

被引：7

作者：

HANEFELD, W

SCHLITZER, M

机构：

[1] Institut für Pharmazeutische Chemie, Marburg, D-35037, Marbacher Weg 6, Lahn

来源：

JOURNAL OF HETEROCYCLIC CHEMISTRY | 1994年 / 31卷 / 02期

关键词：

D O I：

10.1002/jhet.5570310223

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

Alpha-Bromoacetylaminorhodanines 1 were reacted with NH4SCN yielding 3-(thiazolidin-3-yl)rhodanines 4, a novel type of rhodanine derivatives bearing a uncommon N-N ring-connection.

引用

页码：391 / 392

页数：2

共 6 条

[1] THE PHARMACOLOGY OF ALDOSE REDUCTASE INHIBITORS [J].

KADOR, PF ;

ROBISON, WG ;

KINOSHITA, JH .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1985, 25 :691-714

[2] THE ROLE OF ALDOSE REDUCTASE IN THE DEVELOPMENT OF DIABETIC COMPLICATIONS [J].

KADOR, PF .

MEDICINAL RESEARCH REVIEWS, 1988, 8 (03) :325-352

[3] ALDOSE REDUCTASE INHIBITORS - A POTENTIAL NEW CLASS OF AGENTS FOR THE PHARMACOLOGICAL CONTROL OF CERTAIN DIABETIC COMPLICATIONS [J].

KADOR, PF ;

KINOSHITA, JH ;

SHARPLESS, NE .

JOURNAL OF MEDICINAL CHEMISTRY, 1985, 28 (07) :841-849

[4]

Sarges R., 1989, ADV DRUG RES, V18, P139

[5] ALDOSE REDUCTASE INHIBITORS AND DIABETIC COMPLICATIONS [J].

TOMLINSON, DR ;

WILLARS, GB ;

CARRINGTON, AL .

PHARMACOLOGY & THERAPEUTICS, 1992, 54 (02) :151-194

[6]

TURKEVICH NM, 1971, DOPOV AKAD NAUK UKR, V33, P1016

← 1 →